Quizartinib, a selective FLT3 inhibitor, maintains anti-leukaemic activity
A study published in the journal Oncotarget has reported a preclinical study, which has characterised the binding…
Browsing: Leukaemia
Study reveals properties of cells fated to relapse in acute lymphoblastic leukaemia
Scientists at St. Jude Children’s Research Hospital and Princess Margaret Cancer Centre in Toronto, Canada,…
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukaemia and lymphoma
According to results from a Phase I/IIa trial at The University of Texas MD Anderson…
Mutation’s role in blood cancers revealed
A genetic mutation that disrupts how DNA sends messages to the rest of a cell…
Cancer cell defect found to be driving resistance to CAR T cell therapy
Study identifying mechanism that prevents cell death may guide future immunotherapy strategies Some cancer cells…
Drug profiling and gene scissors open new avenues in immunotherapy
Researchers have discovered ways to boost CAR T-cell therapy. According to a study published in…
Elevated leukaemia incidence is found in World Trade Center rescue and recovery workers
Rescue and recovery personnel who worked at the World Trade Center site after the attacks…
Research collaboration reveals promising drug candidate for treatment of blood cancers
Today, OncoTartis, Inc. and Children’s Cancer Institute jointly announced the publication of two research manuscripts…
Cancer study may accidentally help researchers create usable blood stem cells
A massive research effort over more than a quarter century has tried to make personalised…
Partnership with China prompts change in care for high-risk type of leukaemia
Researchers from St. Jude Children’s Research Hospital, USA, and the Chinese Children’s Cancer Group led…